Tony Hung is an investor in early-stage technologies in healthcare and biotech. With over 15 years of experience as an inventor, scientific founder, and entrepreneur behind life science startups in both Silicon Valley and Boston, Tony is applying his scientific and operational background towards how to better translate basic research and fundamental discoveries into therapies, diagnostics, devices, and outcomes that directly help people and patients. He passionately believes in the power to have profound impact through the organization of small groups of motivated and talented teams.
Tony serves as an adviser and on the board of several private companies in the areas of genomics, synthetic biology, gene delivery, and early detection/diagnostics. He has engineering and science degrees from Stanford and Harvard University.